Novik, A. V., Yaremenko, E. V., Anokhina, E. M., Nehaeva, T. L., Semenova, A. I., Latipova, D. K., . . . Baldueva, I. A. (2019). RECIST 1.1 AND irRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Tomsk National Research Medical Center of the Russian Academy of Sciences.

Novik, A. V., E. V. Yaremenko, E. M. Anokhina, T. L. Nehaeva, A. I. Semenova, D. Kh Latipova, S. A. Protsenko, and I. A. Baldueva. RECIST 1.1 AND IrRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Tomsk National Research Medical Center of the Russian Academy of Sciences, 2019.

Novik, A. V., et al. RECIST 1.1 AND IrRC FOR RESPONSE ASSESMENT IN PATIENTS WITH DISSEMINATED CUTANEOUS MELANOMA TREATED WITH IPILIMUMAB OR DENDRITIC CELL VACCINE. Tomsk National Research Medical Center of the Russian Academy of Sciences, 2019.